Andrew A. Dahl

Insider Reports History

Location
Bloomfield Hills, MI
Signature
/s/ Andrew A. Dahl
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew A. Dahl:

Form 4 holding President / CEO, Director

Zivo Bioscience, Inc.

Security class
Nonstatutory Stock Option to Purchase Common Stock
Shares / value
376,000
Estimated value
Report date
21 Oct 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Andrew A. Dahl

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .